Screener
TransCode Therapeutics, Inc. RNAZ Q2 2026 earnings
Reported August 14, 2026 · Before market open
EPS-$7.17
Next report
Nov 18, 2026 (In 2 weeks)Versus estimates
FAQ
- When did TransCode Therapeutics, Inc. report Q2 2026 earnings?
- TransCode Therapeutics, Inc. (RNAZ) reported Q2 2026 earnings on August 14, 2026 before market open.
- What were TransCode Therapeutics, Inc.'s Q2 2026 revenue and EPS?
- TransCode Therapeutics, Inc. reported eps of $-7.17 for Q2 2026.
- How did TransCode Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 45.1% from $-4.94.
- Where can I find TransCode Therapeutics, Inc.'s Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001829635-26-000003) directly on SEC EDGAR. The filing index links above go to sec.gov.
